News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
Content Sharing
<Research>Citi: ASMPT (00522.HK) Biz Fundamentals Improving; Rating Reiterated at Buy
ASMPT (00522.HK)'s share price rebounded over 5% in the morning session yesterday (14th), breaking the historical resistance level of $120 for the first time since 2021, Citi R...
Reset
Send
The window will close in 5 seconds
<Research>Citi: ASMPT (00522.HK) Biz Fundamentals Improving; Rating Reiterated at Buy
Close
Recommend
8
Positive
17
Negative
8
 
 

ASMPT (00522.HK)  +10.700 (+6.926%)    Short selling $57.01M; Ratio 6.235%   's share price rebounded over 5% in the morning session yesterday (14th), breaking the historical resistance level of $120 for the first time since 2021, Citi Research issued a research report saying.

The broker believed that the share price strength was mainly driven by news reports that ASMPT recently demonstrated its HBM TCB technology to Samsung Electronics, with the project having entered a joint evaluation stage.

Related News Huatai Securities Raises ASMPT (00522.HK) TP to HKD200, Maintains Buy
As the industry increases capital expenditure in advanced packaging, ASMPT's business fundamentals are improving, Citi Research noted. The Company continued to streamline operations, including the potential disposal of its NEXX and SMT businesses, which could drive a valuation re-rating beyond its historical range, in the broker's view.

Therefore, Citi Research reiterated rating at Buy on ASMPT, with a target price of $145.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-04-24 16:25.)

Auto-translated by AI

AASTOCKS Financial News

Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.